Defence Therapeutics Inc.
DTC
Ранг среди акций
#29522
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Цена акции
$0.25964327
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$19.68M
Изменение (1 день)
0.00%
Изменение (1 год)
-55.64%
Страна
CA
Торговля Defence Therapeutics Inc. (DTC)
Категория
Healthcare
История цены акций Defence Therapeutics Inc. (DTC)
Наивысшая цена закрытия: $0.27 2026-10-01
Наименьшая цена закрытия: $2.50 2021-05-01
Наименьшая цена закрытия: $2.50 2021-05-01
История цены акций Defence Therapeutics Inc. с 2021 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | -27.66% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.50 | -4.01% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
